FIGHTING THE GLOBAL CHALLENGE

Syringe reuse and drug tampering is a worldwide everyday threat endangering the lives of millions. 6.7 billion people in the underdeveloped countries alone are injected with reused syringes every year. It is estimated that more than 24 million of these are infected with a disease from this.

On the 23 February 2015 the WHO officially urged that all syringes must be replaced by intelligent syringes latest by 2020.

This is a statement in line with CDC (Center of Disease Control) after syringe reuse has been discovered on several occasions in the US. And the same pattern is emerging in other industrial countries all over the world.

Injecto AS has developed and patented a highly efficient pre-filled auto-disabled syringe with a material and component structure that ensures a highly cost efficient price structure.

.

The Injecto product advantages

Injecto offers a compact injection package combining the primary drug container made of Cyclic Olefin Copolymer with an injection device, which can be used for IM, SC and ID injections worldwide.The design combines user friendliness and reuse prevention in one injection package with versatile use for a wide variety of injectables in different volumes.

The dual functionality of the needle cap eliminates the traditional plunger and considerably reduces volume and weight of the product and the risk of inadvertent plunger activation.

Injecto is a genuine Solution 1 AD syringe where the feature against reuse is automatically activated by the initialization of the injection. This feature further contributes to preventing falsification and tampering with pharmaceutical products.

The component materials with very low extractables accommodate necessary shelf life for drugs and provide good chemical resistance and oxygen and moisture barriers. We believe that everyone is entitled to safe injections by the use of pre-filled devices safeguarded against reuse.

.

 The global solution

Injecto offers a compact injection package combining the primary drug container made of Cyclic Olefin Copolymer with an injection device, which can be used for IM, SC and ID injections worldwide.The design combines user friendliness and reuse prevention in one injection package with versatile use for a wide variety of injectables in different volumes.

 The global market

The current value of the global market is 3.5-4 billion US$ per year with an annual growth rate of 10-13,8 % and a forecasted value of 5.6-7.6 billion US$ in 2020.

STATISTICS FROM DEVELOPING COUNTRIES

Billion Injections

Billion Re-used Injections

Million Re-infected Patients